title: Terlipressin for haemodynamic support in septic patients: a double-edged sword?
authors.forename: Martin
authors.initials: M
authors.lastname: Westphal
authors.forename: Hans-Georg
authors.initials: HG
authors.lastname: Bone
authors.forename: Hugo
authors.initials: H
authors.lastname: Van Aken
authors.forename: Andreas Wilhelm
authors.initials: AW
authors.lastname: Sielenkämper
mesh_terms: D000818:Animals; D006439:Hemodynamics / Q000187:drug effects; D006801:Humans; D007413:Intestinal Mucosa / Q000098:blood supply* / Q000187:drug effects*; D007511:Ischemia / Q000139:chemically induced*; D008236:Lypressin / Q000008:administration & dosage / Q000009:adverse effects* / Q000031:analogs & derivatives*; D012772:Shock, Septic / Q000188:drug therapy*; D000077585:Terlipressin; D014662:Vasoconstrictor Agents / Q000008:administration & dosage / Q000009:adverse effects*
chemical_list: D014662:Vasoconstrictor Agents; D008236:Lypressin; D000077585:Terlipressin